Extranodal NK-T-cell lymphoma medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
| style="padding: 5px 5px; background: #DCDCDC;" | Radiation therapy | | style="padding: 5px 5px; background: #DCDCDC;" | Radiation therapy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* If extranodal NK | * If extranodal NK-T-cell lymphoma is confined to the nose or nasal passages, [[external beam radiation therapy]] is used | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" | Chemotherapy | | style="padding: 5px 5px; background: #DCDCDC;" | Chemotherapy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Chemotherapy is often added to radiation therapy to treat extranodal NK/T-cell lymphoma | * Chemotherapy is often added to radiation therapy to treat extranodal NK/T-cell lymphoma | ||
* If extranodal NK | * If extranodal NK-T-cell lymphoma is more widespread, then [[chemotherapy]] may be more intense and higher doses may be used | ||
* Drug regimen: (CHOP) [[Cyclophosphamide]] {{and}} [[Doxorubicin]] {{and}} [[Vincristine]] {{and}} [[Prednisone]] | * Drug regimen: (CHOP) [[Cyclophosphamide]] {{and}} [[Doxorubicin]] {{and}} [[Vincristine]] {{and}} [[Prednisone]] | ||
* CNS Prophylaxis: [[Methotrexate]] | * CNS Prophylaxis: [[Methotrexate]] | ||
Line 25: | Line 25: | ||
| style="padding: 5px 5px; background: #DCDCDC;" | Stem cell transplant | | style="padding: 5px 5px; background: #DCDCDC;" | Stem cell transplant | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* May be offered to some people with extranodal NK | * May be offered to some people with extranodal NK-T-cell lymphoma who relapse after initial treatment | ||
|} | |} | ||
==References== | ==References== |
Revision as of 14:04, 3 February 2016
Extranodal NK-T-cell lymphoma Microchapters |
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma medical therapy On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma medical therapy |
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
The predominant therapy for extranodal NK-T-cell lymphoma is radiation therapy. Adjunctive chemotherapy and stem cell transplant may be required.[1]
Medical Therapy
The predominant therapy for extranodal NK-T-cell lymphoma is radiation therapy. Adjunctive chemotherapy and stem cell transplant may be required.
Therapy | Description |
---|---|
Radiation therapy |
|
Chemotherapy |
|
Stem cell transplant |
|
References
- ↑ 1.0 1.1 Extranodal NK/T-cell lymphoma, nasal type. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/extranodal-nk-t-cell-lymphoma-nasal-type/?region=on. Accessed on February 02, 2016